PI-103
PI-103 is a potent, ATP-competitive small molecule inhibitor targeting key PI3K isoforms, mTOR, and DNA-PK. It is widely used in preclinical research to investigate oncogenic signaling pathways and has demonstrated antitumor activity in both cellular assays and in vivo cancer models.
Product Specifications
CAS Number
371935-74-9
Product Name Alternative
DNA-PK, DNAPK, DNA-dependent protein kinase, Apoptosis, Autophagy, Mammalian target of Rapamycin, mTOR, inhibit, Inhibitor, p110α, p110β, p110δ, p110γ, PI103, PI-103, PI 103, PI3K, Phosphoinositide 3-kinase
Field of Research
Cancer Biology, Cell Biology, Neuroscience
Purity
>98%
Bioactivity
PI3K, mTOR and DNA-PK inhibitor
Form
Powder
Solubility
Soluble in DMSO (40 mg/ml)
Smiles
Oc1cccc (c1) -c1nc (N2CCOCC2) c2oc3ncccc3c2n1
Molecular Formula
C19H16N4O3
Molecular Weight
348.4
Storage Conditions
-20°C
Notes
For research use only.
Other Product Names
3-[4- (4-morpholinyl) pyrido[3’,2’:4,5]furo[3,2-d]pyrimidin-2-yl]-phenol
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog